Skip to Main

Search

Results 121 to 130 of 993 for ""

UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-pneumococcal-vaccine.html

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against infection.

Defect in gene caused massive obesity in mice despite normal food intake: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-defect-in-gene.html

A faulty gene, rather than a faulty diet, may explain why some people gain excessive weight even when they don’t eat more than others.

Tumor mutations may not predict response to immunotherapy: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/may-tumor-mutations.html

The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern Medical Center reported in a retrospective study.

Study links chronic pain to quality of family relationships: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/june-chronic-pain.html

– Strong family relationships have long been associated with a better sense of well-being and connection. Now a research team led by UT Southwestern Medical Center has linked the quality of those relationships with how successfully people – particularly aging African Americans – manage pain.

UTSW Research: Food allergies, weight-loss surgery, and more: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-research-roundup.html

Millions of children have food allergies, many of which can cause severe illness or death. In a study published in the New England Journal of Medicine, a team of researchers, including those from UT Southwestern, shows in a phase three clinical trial that an antibody-based therapy called omalizumab may inhibit food allergy reactions when delivered repeatedly over time.

Eating at the right time is important for health, UTSW study shows : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/june-health-eat.html

Cutting calories and limiting nighttime snacking is known to improve health and extend your lifespan. But would only eating during certain hours of the day have a similar effect on healthspan, or the length of time a person is healthy and free from disease?

Exertion tests offer insight into recovery from youth concussions : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/july-exertion-tests.html

Clinical exams that incorporate gait analysis after physical exertion may provide insight into how youths are recovering after concussions to help determine whether they are ready to return to sports, UT Southwestern Medical Center and Scottish Rite for Children (SRC) physicians found.

UTSW introduces single-port robotic surgery for lung cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/june-lobectomy.html

A team at UT Southwestern Medical Center is the first in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.

Findings could boost efforts to develop chlamydia vaccine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/june-chlamydia-vaccine.html

Scientists at UT Southwestern Medical Center, working with other U.S. researchers, have uncovered the structure of a key cell membrane protein in a bacterial model for Chlamydia trachomatis, the cause of the world’s most common bacterial sexually transmitted infection (STI).

FDA expands use of kidney cancer drug developed from UTSW research: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/june-belzutifan-fda.html

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.